Rituximab in pediatric refractory nephrotic syndrome: a systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles.

BACKGROUND: Rituximab is considered a therapeutic option in children with refractory nephrotic syndrome (RNS). However, the efficacy and safety of rituximab treatment remain unclear. OBJECTIVE: This study systematically evaluated the clinical effecti…

Preview only. Read the full abstract at the source